Neuphoria Therapeutics Inc (NEUP) — Capital Reinvestment Ratio
Neuphoria Therapeutics Inc (NEUP) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($73.57 Million) in capital expenditures ($3.00). See NEUP equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Neuphoria Therapeutics Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks Neuphoria Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check NEUP cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Neuphoria Therapeutics Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for Neuphoria Therapeutics Inc from 2015 to 2015. For live market cap and broader valuation context, see market cap of Neuphoria Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.13x | $4.94 Million | $649.08K | — |